Skip to main content
SpringerLink
Log in

19 Medicamenteuze behandeling

  • Chapter
Handboek persoonlijkheidspathologie

Samenvatting

Sinds de late jaren zeventig van de vorige eeuw is er sprake van een opmerkelijk groeiend optimisme ten aanzien van de effectiviteit van farmacotherapeutische interventies bij patiënten met een persoonlijkheidsstoornis. Maar is dit optimisme gerechtvaardigd?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatuur

  • Akiskal, H.S. (1994). The temperamental borders of affective disorders. Acta Psychiatrica Scandinavica Suppl, 379, 32-37.

    Google Scholar 

  • Akiskal, H.S., Hantouche, E.G. & Allilaire, J.F. (2003). Bipolar II with and without cyclothymic temperament: ‘dark’ and ‘sunny’ expressions of soft bipolarity. Journal of Affective Disorders, 73, 49-57.

    Google Scholar 

  • APA (American Psychiatric Association) (2001). Practice guideline for the treatment of patients with borderline personality disorder. American Journal of Psychiatry, 158, 1-52.

    Google Scholar 

  • Bogenschutz, M.P. & George, N.H. (2004). Olanzapine versus placebo in the treatment of borderline personality disorder. Journal of Clinical Psychiatry, 65, 104-109.

    Google Scholar 

  • Cloninger, C.R. (1987). A systemic method for clinical description and classification of personality variants. A proposal. Archives of General Psychiatry, 44, 573-588.

    Google Scholar 

  • Cloninger, C.R., Svrakic, D.M. & Przybeck, T.R. (1993). A psychological model of temperament and character. Archives of General Psychiatry, 50, 975-990.

    Google Scholar 

  • Coccaro, E.F. & Kavoussi, R.J. (1997). Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Archives of General Psychiatry, 54, 1081-1088.

    Google Scholar 

  • Cornelius, J.R., Soloff, P.H., George, A., Ulrich, R.F. & Perel, J.M. (1993). Haloperidol vs. phenelzine in continuation therapy of borderline disorder. Psychopharmacological Bulletin, 29, 333-337.

    Google Scholar 

  • Cornelius, J.R., Soloff, P.H., Perel, J.M. & Ulrich, R.F. (1993). Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine. American Journal of Psychiatry, 150, 1843-1848.

    Google Scholar 

  • Cowdry, R.W. & Gardner, D.L. (1988). Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Archives of General Psychiatry, 45, 111-119.

    Google Scholar 

  • De la Fuente, J.M. & Lotstra, F. (1994). A trial of carbamazepine in borderline personality disorder. European Neuropsychopharmacology, 4, 479-486.

    Google Scholar 

  • Farwell, W.R., Stump, T.E., Wang, J., Tafesse, E., L’Italien, G. & Tierney, W. M. (2004). Weight gain and new onset diabetes associated with olanzapine and risperidone. Journal of General Internal Medicine, 19, 1200-1205.

    Google Scholar 

  • Gardner, D.L. & Cowdry, R.W. (1985). Alprazolam-induced dyscontrol in borderline personality disorder. American Journal of Psychiatry, 142, 98-100.

    Google Scholar 

  • Gardner, D.L. & Cowdry, R.W. (1986). Development of melancholia during carbamazepine treatment in borderline personality disorder. Journal of Clinical Psychopharmacology, 6, 236-239.

    Google Scholar 

  • Gardner, D.L. & Cowdry, R.W. (1986). Positive effects of carbamazepine on behavioural dyscontrol in borderline personality disorder. American Journal of Psychiatry, 143, 519-522.

    Google Scholar 

  • Gitlin, M.J. (1993). Pharmacotherapy of personality disorders: conceptual framework and clinical strategies. Journal of Clinical Psychopharmacology, 13, 343-353.

    Google Scholar 

  • Goldberg, S.C., Schulz, S.C., Schulz, P.M., Resnick, R.J., Hamer, R.M. & Friedel, R.O. (1986). Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo. Archives of General Psychiatry, 43, 680-686.

    Google Scholar 

  • Hollander, E., Allen, A., Lopez, R.P., Bienstock, C.A., Grossman, R., Siever, L.J., e.a. (2001). A preliminary double-blind, placebo-controled trial of divalproex sodium in borderline personality disorder. Journal of Clinical Psychiatry, 62, 199-203.

    Google Scholar 

  • Hollander, E., Swann, A.C., Coccaro, E.F., Jiang, P. & Smith, T.B. (2005). Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. American Journal of Psychiatry, 162, 621-624.

    Google Scholar 

  • Hollander, E., Tracy, K.A., Swann, A.C., Coccaro, E.F., McElroy, S.L., Wozniak, P., e.a. (2003). Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology, 28, 1186-1197.

    Google Scholar 

  • Koenigsberg, H.W., Reynolds, D., Goodman, M., New, A.S., Mitropoulou, V., Trestman, R.L., e.a. (2003). Risperidone in the treatment of schizotypal personality disorder. Journal of Clinical Psychiatry, 64, 628-634.

    Google Scholar 

  • Liebowitz, M.R., Quitkin, F.M., Steward, J.W., McGrath, P.J., Harrison, W.M., Markowitz, J.S., e.a. (1988). Antidepressant specificity in atypical depression. Archives of General Psychiatry, 45, 129-137.

    Google Scholar 

  • Links, P.S., Steiner, M., Boiago, I. & Irwin, D. (1990). Lithium therapy for borderline patients: preliminaryfindings. Journal of Personality Disorders, 4, 173-181.

    Google Scholar 

  • Loewe, T.H., Nickel, M.K., Meuhlbacher,M., Kaplan, P., Nickel, C., Kettler, C., e.a. (2006). Topiramate treatment for women with borderline personality disorder. Journal of Clinical Psychopharmacology, 26, 61-66.

    Google Scholar 

  • Montgomery, S.A. & Montgomery, D. (1982). Pharmacological prevention of suicidal behaviour. Journal of Affective Disorders, 4, 291-298.

    Google Scholar 

  • Montgomery, S.A., Roy, D. & Montgomery, D.B. (1983). The prevention of recurrent suicidal acts. British Journal of Clinical Pharmacology, 15 Suppl 2, 183S-188S.

    Google Scholar 

  • Nickel, M.K., Nickel, C., Kaplan, P., Lahmann, C., Muhlbacher, M., Tritt, K., e.a. (2005). Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controled study. Biological Psychiatry, 57, 495-499.

    Google Scholar 

  • Nickel, M.K., Nickel, C., Mitterlehner, F.O., Tritt, K., Lahmann, C., Leiberich, P.K., e.a. (2004). Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controled study. Journal of Clinical Psychiatry, 65, 1515-1519.

    Google Scholar 

  • Nickel, M.K., Meuhlbacher, M., Nickel, C., Kettler, C., Gil, F.P., Bachler, E., e.a. (2006). Aripiprazole in the treatment of patients with borderline personality disorder; a double-blind, placebo-controled study. American Journal of Psychiatry, 163, 833-838.

    Google Scholar 

  • Parsons, B., Quitkin, F.M., McGrath, P.J., Stewart, J.W., Tricamo, E., Ocepek-Welikson, K., e.a. (1989). Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression. Psychopharmacological Bulletin, 25, 524-534.

    Google Scholar 

  • Philipsen, A., Schmahl, C. & Lieb, K. (2004). Naloxone in the treatment of acute dissociative states in female patients with borderline personality disorder. Pharmacopsychiatry, 37, 196-199.

    Google Scholar 

  • Rinne, T., van den, B.W., Wouters, L. & Dyck, R. van (2002). SSRI treatment of borderline personality disorder: a randomized, placebo-controled clinical trial for female patients with borderline personality disorder. American Journal of Psychiatry, 159, 2048-2054.

    Google Scholar 

  • Salzman, C., Wolfson, A.N., Schatzberg, A., Looper, J., Henke, R., Albanese, M., e.a. (1995). Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. Journal of Clinical Psychopharmacology, 15, 23-29.

    Google Scholar 

  • Siever, L.J. & Davis, K.L. (1991). A psychobiological perspective on the personality disorders. American Journal of Psychiatry, 148, 1647-1658.

    Google Scholar 

  • Simpson, E.B., Yen, S., Costello, E., Rosen, K., Begin, A., Pistorello, J. & Pearlstein, T. (2004). Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder. Journal of Clinical Psychiatry, 65, 379-385.

    Google Scholar 

  • Soler, J., Pascual, J.C., Campins, M.J., Barrachina, J., Puigdemont, D., Alvarez, E. & Perez, V. (2005). Double-blind, placebo-controled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. American Journal of Psychiatry, 162, 1221-1224.

    Google Scholar 

  • Soloff, P.H. (1998). Symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation. Bulletin of the Menninger Clinic, 62, 195-214.

    Google Scholar 

  • Soloff, P.H. (2000). Psychopharmacology of borderline personality disorder. The Psychiatric Clinics of North America, 23, 169-92, ix.

    Google Scholar 

  • Soloff, P.H., Cornelius, J., George, A., Nathan, S., Perel, J.M. & Ulrich, R.F. (1993). Efficacy of phenelzine and haloperidol in borderline personality disorder. Archives of General Psychiatry, 50, 377-385.

    Google Scholar 

  • Soloff, P.H., George, A., Nathan, R.S., Schulz, P.M. & Perel, J.M. (1986a). Paradoxical effects of amitriptyline on borderline patients. American Journal of Psychiatry, 143, 1603-1605.

    Google Scholar 

  • Soloff, P.H., George, A., Nathan, R. S., Schulz, P. M., Ulrich, R.F. & Perel, J.M. (1986b). Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo. Archives of General Psychiatry, 43, 691-697.

    Google Scholar 

  • Soloff, P.H., George, A., Nathan, S., Schulz, P. M., Cornelius, J.R., Herring, J. & Perel, J.M. (1989). Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. Journal of Clinical Psychopharmacology, 9, 238-246.

    Google Scholar 

  • Trestman, R.L., Keefe, R.S., Mitropoulou, V., Harvey, P.D., deVegvar, M.L., Lees-Roitman, S., e.a. (1995). Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder. Psychiatry Research, 59, 127-136.

    Google Scholar 

  • Tritt, K., Nickel, C., Lahmann, C., Lieberich, P.K., Rother, W.K., Loew, T.H., e.a. (2005). Lamotrigine treatment of aggression in female borderline patients: a randomized, double-blind, placebo-controled study. Journal of Psychofarmacology, 19(3), 287-291.

    Google Scholar 

  • Zanarini, M.C. & Frankenburg, F.R. (2001). Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controled pilot study. Journal of Clinical Psychiatry, 62, 849-854.

    Google Scholar 

  • Zanarini, M.C. & Frankenburg, F.R. (2003). Omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controled pilot study. American Journal of Psychiatry, 160, 167-169.

    Google Scholar 

  • Zanarini, M.C., Frankenburg, F.R. & Parachini, E.A. (2004). A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. Journal of Clinical Psychiatry, 65, 903-907.

    Google Scholar 

Download references

Authors
  1. Theo Ingenhoven
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Rinne
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

E.H.M. Eurelings-Bontekoe R. Verheul W.M. Snellen

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Bohn Stafleu van Loghum, onderdeel van Springer Uitgeverij

About this chapter

Cite this chapter

Ingenhoven, T., Rinne, T. (2009). 19 Medicamenteuze behandeling. In: Eurelings-Bontekoe, E., Verheul, R., Snellen, W. (eds) Handboek persoonlijkheidspathologie. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-6821-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-90-313-6821-1_19

  • Publisher Name: Bohn Stafleu van Loghum, Houten

  • Print ISBN: 978-90-313-6112-0

  • Online ISBN: 978-90-313-6821-1

  • eBook Packages: Dutch language eBook collection

Publish with us

Policies and ethics

Search

Navigation